Hepatocellular damage from non-steroidal anti-inflammatory drugs

NSAID-induced hepatotoxicity must be considered in the differential diagnosis of all patients presenting with a spectrum of disease, ranging from isolated deranged liver function tests in an otherwise well patient, to fulminant hepatic failure. Because of the availability of these drugs over the counter, many patients will not disclose their use of these agents to their doctor as they do not perceive them to be 'prescribed' medication. The quoted incidence of NSAID-induced hepatotoxicity is likely to represent significant under-reporting of the condition, as many cases are subclinical and are never detected, or are detected fortuitously as part of a routine biochemical work-up and may not be correctly ascribed to their true aetiology.

Hepatocellular damage from non-steroidal anti-inflammatory drugs

hepatocellular damage from non-steroidal anti-inflammatory drugs

Media:

hepatocellular damage from non-steroidal anti-inflammatory drugshepatocellular damage from non-steroidal anti-inflammatory drugshepatocellular damage from non-steroidal anti-inflammatory drugshepatocellular damage from non-steroidal anti-inflammatory drugshepatocellular damage from non-steroidal anti-inflammatory drugs

http://buy-steroids.org